NCT00297219View on ClinicalTrials.gov

Effects of Lowering Dialysate Calcium Level on Progression of Coronary Artery Calcification and Bone Histomorphometry

NACompletedINTERVENTIONAL
Enrollment

457

Participants

Timeline

Start Date

November 30, 2005

Primary Completion Date

July 31, 2008

Study Completion Date

July 31, 2008

Conditions
End-Stage Renal DiseaseHemodialysis
Interventions
DRUG

Low dialysate calcium

1.25 mmol/L dialysate calcium

DRUG

high dialysate calcium

1.75 mmol/L dialysate calcium

Trial Locations (3)

35100

Ege University School of Medicine, Bornova-Izmir

40536-0084

University of Kentucky Medical Center, Lexington

Unknown

FMC Clinics, Bornova

All Listed Sponsors
collaborator

University of Kentucky

OTHER

collaborator

Fresenius Medical Care North America

INDUSTRY

lead

Ege University

OTHER

NCT00297219 - Effects of Lowering Dialysate Calcium Level on Progression of Coronary Artery Calcification and Bone Histomorphometry | Biotech Hunter | Biotech Hunter